- |||||||||| hydroxychloroquine / Generic mfg., ivermectin oral / Generic mfg.
Journal: Selenium in the Prevention of SARS-CoV-2 and Other Viruses. (Pubmed Central) - Mar 20, 2022 There have been demonstrably effective treatments that proved to be effective but were rapidly dismissed for unknown reasons, such as ivermectin and hydroxychloroquine...The properties of this element provide hope in preventing the development of the SARS-CoV-2 virus. The aim of this review is to synthesize the latest literature data and to present the effect of sodium selenite in reducing the incidence of COVID-19 disease.
- |||||||||| ivermectin oral / Generic mfg.
Review, Journal: Unexpected subungual Sarcoptes infestation of toenail - a case report and literature review. (Pubmed Central) - Mar 19, 2022 It seems that the crucial for adequate diagnosis in scabies affected nails is a precise anamnesis, early and accurate diagnosis that consists of examining not only skin lesions, but including assessing toenails, and differentiation of Sarcoptes infestation from other nail diseases as onychomycosis or psoriasis. Important to achieving a cure is at least frequent nail trimming, softening the nail plate with urea or in the difficult cases the mechanical removal of subungual plaque with using of a scabicide in the location allowing to penatrate it under the nail plate.
- |||||||||| Review, Journal: Pharmacological treatment of COVID-19: an opinion paper. (Pubmed Central) - Mar 18, 2022
The development of vaccines has not prevented, during the whole period of the pandemic, the constant search for therapeutic medicines, both among existing drugs with different indications and in the development of new drugs. The Scientific Committee of the COVID-19 of the Illustrious College of Physicians of Madrid wanted to offer an early, simplified and critical approach to these new drugs, to new developments in immunotherapy and to what has been learned from the immune response modulators already known and which have proven effective against the virus, in order to help understand the current situation.
- |||||||||| ivermectin oral / Generic mfg.
Journal: Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19). (Pubmed Central) - Mar 18, 2022 Modulation of the immune response has become a mainstay of treatment of COVID-19, although the optimal mechanism has not yet been defined and there is considerable controversy regarding clinical management. As time progresses, the therapeutic approach to COVID-19 will undoubtedly change, particularly as we learn more about the pathophysiology of SARS-CoV-2 infection.
- |||||||||| ivermectin oral / Generic mfg.
Journal: Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients. (Pubmed Central) - Mar 18, 2022 Similarly, mortality was lower in the ivermectin group in the full group analysis (1.5 vs. 2.1%, odds ratio 0.720; p = 0.029), as well as in subjects ≥ 40 year- old (2.7 vs. 4.1%, odds ratio 0.655; p = 0.005). This report highlights the safety and possible efficacy of high dose ivermectin as a potentially useful intervention deserving public health-based consideration for COVID-19 patients.
|